Natus Medical Free Cash Flow per Share Trend

BABY -- USA Stock  

USD 34.85  1.20  3.57%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Free Cash Flow per Share of Natus Medical Incorporated with missing and latest data points interpolated. Free Cash Flow per Share is a valuation metric calculated by dividing Free Cash Flow by Weighted Average Shares.
View

1.67 times

          10 Years Trend
Increasing
Slightly volatile
 Free Cash Flow per Share 
      Timeline 

Natus Medical Regression Statistics

Arithmetic Mean 0.94
Coefficient Of Variation 87.66
Mean Deviation 0.62
Median 1.01
Standard Deviation 0.82
Sample Variance 0.68
Range 2.89
R Value 0.89
Mean Square Error 0.16
R Squared 0.79
Significance 0.00012228
Slope 0.20
Total Sum of Squares 7.46

Natus Medical Free Cash Flow per Share Over Time

2016-12-31  2.14 
2017-12-31  2.14 
2018-12-31  1.67 

Other Fundumenentals of Natus Medical Incorp

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Natus Medical Upcoming Events

Natus Medical Upcoming Company Events

Upcoming Quarterly ReportApril 19, 2017
Next Earnings ReportJuly 19, 2017
Check also analysis of Natus Medical Correlation with competitors. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com